Correlation between Oncogenic Mutations and Parameter Sensitivity of the Apoptosis Pathway Model

PLoS Computational Biology

Volumn 10, Issue 1, 2014, Pages

  Chen, Jia ^a   Yue, Haicen ^a,b   Ouyang, Qi ^a,b  

^a Tsinghua University   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIFURCATION (MATHEMATICS); CELL DEATH; GENE EXPRESSION; SENSITIVITY ANALYSIS;

APOPTOSIS PATHWAYS; APOPTOTIC PATHWAYS; BIFURCATION POINTS; BIOLOGICAL NETWORKS; DNA DAMAGES; DYNAMICS EQUATION; ONCOGENESIS; ONCOGENICS; PARAMETER SENSITIVITIES; REGULATORY NETWORK;

PROTEINS;

CASPASE 3; PROTEIN P53;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DNA DAMAGE; GENE EXPRESSION; GENE FUNCTION; GENE ISOLATION; GENE MUTATION; GLIOBLASTOMA; MOLECULAR EVOLUTION; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; SKIN CANCER; STEADY STATE; TUMOR GENE;

ALGORITHMS; APOPTOSIS; CASPASE 3; COMPUTER SIMULATION; DNA DAMAGE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HUMANS; MODELS, BIOLOGICAL; MUTATION; NEOPLASMS; PROTEINS; SIGNAL TRANSDUCTION;

EID: 84896719301     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1003451     Document Type: Article

References (51)

1. Garcia M, Jemal A, Ward E, Center M, Hao Y, et al. (2007) Global cancer facts & figures 2007. Atlanta, GA: American Cancer Society 1.
2. Vogelstein B, Kinzler KW, (2004) Cancer genes and the pathways they control. Nature medicine 10: 789-799.
3. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, et al. (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321: 1801-1806.
4. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, et al. (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321: 1807-1812.
5. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061-1068.
6. Torkamani A, Schork NJ, (2009) Identification of rare cancer driver mutations by network reconstruction. Genome research 19: 1570-1578.
7. Cerami E, Demir E, Schultz N, Taylor BS, Sander C, (2010) Automated network analysis identifies core pathways in glioblastoma. PloS one 5: e8918.
8. Stites EC, Trampont PC, Ma Z, Ravichandran KS, (2007) Network analysis of oncogenic Ras activation in cancer. Science 318: 463-467.
9. Soussi T, Lozano G, (2005) p53 mutation heterogeneity in cancer. Biochemical and biophysical research communications 331: 834-842.
10. Lev Bar-Or R, Maya R, Segel LA, Alon U, Levine AJ, et al. (2000) Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study. Proceedings of the National Academy of Sciences of the United States of America 97: 11250-11255.
11. Chen X, Chen J, Gan S, Guan H, Zhou Y, et al. (2013) DNA damage strength modulates a bimodal switch of p53 dynamics for cell-fate control. BMC biology 11: 73.
12. Li Z, Ni M, Li J, Zhang Y, Ouyang Q, et al. (2010) Decision making of the p53 network: Death by integration. Journal of theoretical biology doi: 10.1016/j.jtbi.2010.11.041.
13. Marine JC, Francoz S, Maetens M, Wahl G, Toledo F, et al. (2006) Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4. Cell death and differentiation 13: 927-934.
14. Michael D, Oren M, (2003) The p53-Mdm2 module and the ubiquitin system. Seminars in cancer biology 13: 49-58.
15. Chehab NH, Malikzay A, Appel M, Halazonetis TD, (2000) Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev 14: 278-288.
16. Stommel JM, Wahl GM, (2004) Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation. Embo J 23: 1547-1556.
17. Vousden KH, Lane DP, (2007) p53 in health and disease. Nature reviews Molecular cell biology 8: 275-283.
18. Salmena L, Pandolfi PP, (2007) Changing venues for tumour suppression: balancing destruction and localization by monoubiquitylation. Nat Rev Cancer 7: 409-413.
19. Chipuk JE, Green DR, (2006) Dissecting p53-dependent apoptosis. Cell Death Differ 13: 994-1002.
20. Cory S, Adams JM, (2002) The Bcl2 family: regulators of the cellular life-or-death switch. Nature reviews Cancer 2: 647-656.
21. Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, et al. (2004) Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303: 1010-1014.
22. Slee EA, Keogh SA, Martin SJ, (2000) Cleavage of BID during cytotoxic drug and UV radiation-induced apoptosis occurs downstream of the point of Bcl-2 action and is catalysed by caspase-3: a potential feedback loop for amplification of apoptosis-associated mitochondrial cytochrome c release. Cell death and differentiation 7: 556-565.
23. Spierings D, McStay G, Saleh M, Bender C, Chipuk J, et al. (2005) Connected to death: the (unexpurgated) mitochondrial pathway of apoptosis. Science 310: 66-67.
24. Leu JI, Dumont P, Hafey M, Murphy ME, George DL, (2004) Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nature cell biology 6: 443-450.
25. Ma L, Wagner J, Rice JJ, Hu W, Levine AJ, et al. (2005) A plausible model for the digital response of p53 to DNA damage. Proceedings of the National Academy of Sciences of the United States of America 102: 14266-14271.
26. Zhang T, Brazhnik P, Tyson JJ, (2007) Exploring mechanisms of the DNA-damage response: p53 pulses and their possible relevance to apoptosis. Cell Cycle 6: 85-94.
27. Batchelor E, Mock CS, Bhan I, Loewer A, Lahav G, (2008) Recurrent initiation: a mechanism for triggering p53 pulses in response to DNA damage. Molecular cell 30: 277-289.
28. Ramalingam S, Honkanen P, Young L, Shimura T, Austin J, et al. (2007) Quantitative assessment of the p53-Mdm2 feedback loop using protein lysate microarrays. Cancer research 67: 6247-6252.
29. Speidel D, Helmbold H, Deppert W, (2006) Dissection of transcriptional and non-transcriptional p53 activities in the response to genotoxic stress. Oncogene 25: 940-953.
30. Haberichter T, Madge B, Christopher RA, Yoshioka N, Dhiman A, et al. (2007) A systems biology dynamical model of mammalian G1 cell cycle progression. Mol Syst Biol 3: 84.
31. Qu Z, Weiss JN, MacLellan WR, (2003) Regulation of the mammalian cell cycle: a model of the G1-to-S transition. Am J Physiol Cell Physiol 284: C349-364.
32. Novak B, Tyson JJ, Gyorffy B, Csikasz-Nagy A, (2007) Irreversible cell-cycle transitions are due to systems-level feedback. Nat Cell Biol 9: 724-728.
33. Yao G, Lee TJ, Mori S, Nevins JR, You L, (2008) A bistable Rb-E2F switch underlies the restriction point. Nat Cell Biol 10: 476-482.
34. Forbes SA, Bhamra G, Bamford S, Dawson E, Kok C, et al. (2008) The Catalogue of Somatic Mutations in Cancer (COSMIC). Current protocols in human genetics/editorial board, Jonathan L Haines [et al] Chapter 10: Unit 10 11.
35. Baudot A, Real FX, Izarzugaza JM, Valencia A, (2009) From cancer genomes to cancer models: bridging the gaps. EMBO reports 10: 359-366.
36. Sakakura C, Sweeney EA, Shirahama T, Igarashi Y, Hakomori S, et al. (1996) Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis. International journal of cancer Journal international du cancer 67: 101-105.
37. Marchenko ND, Zaika A, Moll UM, (2000) Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. The Journal of biological chemistry 275: 16202-16212.
38. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, et al. (2003) p53 has a direct apoptogenic role at the mitochondria. Molecular cell 11: 577-590.
39. Dewson G, Ma S, Frederick P, Hockings C, Tan I, et al. (2012) Bax dimerizes via a symmetric BH3:groove interface during apoptosis. Cell death and differentiation 19: 661-670.
40. Michor F, Iwasa Y, Nowak MA, (2004) Dynamics of cancer progression. Nature reviews Cancer 4: 197-205.
41. Knudson AG, (2001) Two genetic hits (more or less) to cancer. Nature reviews Cancer 1: 157-162.
42. Leary RJ, Lin JC, Cummins J, Boca S, Wood LD, et al. (2008) Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers. Proceedings of the National Academy of Sciences 105: 16224.
43. Kaminker JS, Zhang Y, Watanabe C, Zhang Z, (2007) CanPredict: a computational tool for predicting cancer-associated missense mutations. Nucleic acids research 35: W595-W598.
44. Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, et al. (2007) Patterns of somatic mutation in human cancer genomes. Nature 446: 153-158.
45. Wagner J, Ma L, Rice JJ, Hu W, Levine AJ, et al. (2005) p53-Mdm2 loop controlled by a balance of its feedback strength and effective dampening using ATM and delayed feedback. Syst Biol (Stevenage) 152: 109-118.
46. Ciliberto A, Novak B, Tyson JJ, (2005) Steady states and oscillations in the p53/Mdm2 network. Cell Cycle 4: 488-493.
47. Hu W, Feng Z, Ma L, Wagner J, Rice JJ, et al. (2007) A single nucleotide polymorphism in the MDM2 gene disrupts the oscillation of p53 and MDM2 levels in cells. Cancer Res 67: 2757-2765.
48. Letai AG, (2008) Diagnosing and exploiting cancer's addiction to blocks in apoptosis. Nature reviews Cancer 8: 121-132.
49. Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, et al. (2005) Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Molecular cell 17: 393-403.
50. Michor F, Iwasa Y, Nowak MA, (2004) Dynamics of cancer progression. Nature Reviews Cancer 4: 197-205.
51. Aldridge BB, Burke JM, Lauffenburger DA, Sorger PK, (2006) Physicochemical modelling of cell signalling pathways. Nature cell biology 8: 1195-1203.